1. Home
  2. CLPT vs BWAY Comparison

CLPT vs BWAY Comparison

Compare CLPT & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ClearPoint Neuro Inc.

CLPT

ClearPoint Neuro Inc.

HOLD

Current Price

$13.27

Market Cap

494.6M

Sector

Health Care

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$22.25

Market Cap

451.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLPT
BWAY
Founded
1998
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
494.6M
451.2M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CLPT
BWAY
Price
$13.27
$22.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$26.50
$26.50
AVG Volume (30 Days)
749.7K
126.1K
Earning Date
02-25-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
213.09
EPS
N/A
0.13
Revenue
$34,332,000.00
$49,094,000.00
Revenue This Year
$18.93
$330.76
Revenue Next Year
$51.64
$22.24
P/E Ratio
N/A
$73.20
Revenue Growth
12.83
27.08
52 Week Low
$9.76
$7.84
52 Week High
$30.10
$25.65

Technical Indicators

Market Signals
Indicator
CLPT
BWAY
Relative Strength Index (RSI) 44.67 49.62
Support Level $12.77 $22.97
Resistance Level $14.33 $25.65
Average True Range (ATR) 0.94 1.37
MACD -0.11 -0.37
Stochastic Oscillator 18.75 20.75

Price Performance

Historical Comparison
CLPT
BWAY

About CLPT ClearPoint Neuro Inc.

ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: